Abstract:Cardiovascular diseases (CVD) are the leading cause of death worldwide, and smoking remains the most significant preventable risk factor. The contribution of nicotine, the addictive component of all tobacco products, to smoking-related CVD remains poorly understood. In addition to smoking, obesity is also a major risk factor for the development of CVD. Recent studies indicate that individuals who are overweight or obese are at greater risk of nicotine product usage. With more than 40% of the US population affected by obesity, the combined effects of obesity and nicotine on cardiovascular (CV) health warrant urgent investigation. In the present study we investigated the combined effects of nicotine exposure and a high fat diet (HFD) on CV function.Male C57BL/6N mice (8 wk-old) were placed on either a HFD (60 kcal% Fat) or standard chow (SC, 22 kcal% Fat) and exposed to room air (RA) or nicotine vapor (NIC, 12 hr/day during the active phase) for 10 weeks (n=10-15/group). Mice with HFD exposure alone exhibited significantly greater weight gain at 10 weeks vs. SC-RA controls (122.5±9.8% increase in body weight in HFD-RA vs. 40.7±3.3% in SC-RA, p < 0.0001), whereas concurrent nicotine inhalation significantly reduced this weight gain (66.5±5.8% in HFD-NIC group, p < 0.0001). In the HFD-NIC group, blood pressure (BP) monitoring via telemetry (24 hours) revealed non-significant increases in BP in the inactive phase, coupled with a significant (p < 0.05) reduction in the expected dipping in BP during the inactive compared to the active phase (HFD-NIC: 4.5±1.2; SC-RA: 11.3±2.2; HFD-RA: 12.4±1.0 and SC-NIC: 9.7±4.6 mmHg). LV catheterization showed that mice exposed to both nicotine and HFD had elevated LV end diastolic pressure (HFD-NIC: 14.1±0.7; SC-RA: 4.5±0.8; HFD-RA: 2.8±0.7 and SC-NIC: 3.9±1.3 mmHg; p<0.05) and prolonged time constant of LV relaxation (Tau). LV RNAseq analysis revealed that HFD-NIC resulted in 70 differentially expressed genes (36 upregulated and 34 downregulated) unique from nicotine or HFD alone, with multiple differentially regulated pathways including dilated cardiomyopathy signaling pathway (p = 2.8E-04). Plasma NT-pro-BNP levels were significantly increased in HFD-RA mice vs. SC-RA controls, whereas this response was absent in HFD-NIC. Finally, HFD+NIC led to greater impairment of endothelium-dependent vasorelaxation in thoracic aortas compared to either treatment alone.In conclusion, although nicotine reduced HFD-induced weight gain, combined exposure to inhaled nicotine and HFD led to greater cardiovascular dysfunction including dysregulation in physiological blood pressure responses, LV diastolic dysfunction, and greater impairment of endothelial-dependent vascular function. National Institute of Health [grant numbers HL135635 (to JDG, EL and XY); HL146098, HL146514, and HL151398 (to DJL.); and F30HL160071 (to AKW)]; Department of Veterans Affairs (BX004294 to EL) and the American Heart Association [Award 829761 (to AKW) and Award 20POST35200075 (to ZL)]. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Activation of AMPKα2 in Adipocytes is Essential for Nicotine-Induced Insulin Resistance in Vivo

Activation of the Cholinergic Antiinflammatory Pathway Ameliorates Obesity-Induced Inflammation and Insulin Resistance

Nicotine Enhances Invasion and Metastasis of Human Colorectal Cancer Cells Through the Nicotinic Acetylcholine Receptor Downstream P38 MAPK Signaling Pathway.

MicroRNA-191, Acting Via the IRS-1/Akt Signaling Pathway, is Involved in the Hepatic Insulin Resistance Induced by Cigarette Smoke Extract

Nicotine activates HIF-1α and regulates acid extruders through the nicotinic acetylcholine receptor to promote the Warburg effect in non-small cell lung cancer cells

Macrophage Alpha 1 Amp-Activated Protein Kinase (alpha 1ampk) Antagonizes Fatty Acid-Induced Inflammation Through Sirt1

Activation of 5-Lipoxygenase is Required for Nicotine Mediated Epithelial-Mesenchymal Transition and Tumor Cell Growth

Nicotine May Affect the Secretion of Adipokines Leptin, Resistin and Visfatin Through Activation of KATP Channel

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

Effects of Nicotine Doses and Administration Frequencies on Mouse Body Weight and Adipose Tissues

Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control

Gut microbial metabolites reveal diet-dependent metabolic changes induced by nicotine administration

Cardiovascular dysfunction induced by combined exposure to nicotine inhalation and high fat diet

In Type 2 Diabetes Induced by Cigarette Smoking, Activation of P38 MAPK is Involved in Pancreatic Β-Cell Apoptosis

Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis

Adiponectin May Be A Biomarker of Early Atherosclerosis of Smokers and Decreased by Nicotine Through Katp Channel in Adipocytes

Cigarette Smoking and Adipose Tissue: the Emerging Role in Progression of Atherosclerosis

Nicotine, Body Weight and Potential Implications in the Treatment of Obesity

Nicotine induces the expression of C-reactive protein via MAPK-dependent signal pathway in U937 macrophages

Nicotine Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice by Activating Α7 Nicotinic Acetylcholine Receptor on Mast Cells

Nicotinamide Reprograms Adipose Cellular Metabolism and Increases Mitochondrial Biogenesis to Ameliorate Obesity